Krečak, I., Skelin, M. & Verstovsek, S. (2023). Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera. Expert Review of Hematology, 16. (5), 305-316. doi: 10.1080/17474086.2023.2199151
Krečak, Ivan, et al. "Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera." Expert Review of Hematology, vol. 16, no. 5, 2023, pp. 305-316. https://doi.org/10.1080/17474086.2023.2199151
Krečak, Ivan, Marko Skelin and Srdan Verstovsek. "Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera." Expert Review of Hematology 16, no. 5 (2023): 305-316. https://doi.org/10.1080/17474086.2023.2199151
Krečak, I., Skelin, M. and Verstovsek, S. (2023) 'Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera', Expert Review of Hematology, 16(5), pp. 305-316. doi: 10.1080/17474086.2023.2199151
Krečak I, Skelin M, Verstovsek S. Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera. Expert Review of Hematology [Internet]. 2023 April 05 [cited 2024 September 30];16(5):305-316. doi: 10.1080/17474086.2023.2199151
I. Krečak, M. Skelin and S. Verstovsek, "Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera", Expert Review of Hematology, vol. 16, no. 5, pp. 305-316, April 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:671197. [Accessed: 30 September 2024]